Antiplatelet agents and diabetic vascular disease.
作者信息
Colwell J A
出版信息
Trans Am Clin Climatol Assoc. 1987;98:119-27.
Abstract
摘要
相似文献
1
Antiplatelet agents and diabetic vascular disease.抗血小板药物与糖尿病血管疾病
Trans Am Clin Climatol Assoc. 1987;98:119-27.
2
Comment on: DiChiara et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.评论：迪恰拉等人（2007年）。阿司匹林剂量对糖尿病和非糖尿病患者血小板功能的影响：阿司匹林诱导血小板效应（ASPECT）研究的分析：《糖尿病》，2007年，第56卷，第3014 - 3019页。
Diabetes. 2008 May;57(5):e10; author reply e11. doi: 10.2337/db08-0173.
3
Antiplatelet therapy.抗血小板治疗。
Am Fam Physician. 1981 Oct;24(4):129-34.
4
[Role of leukocytes and thrombocytes in lung damage in hemorrhagic shock. Protective effect of aspirin and dipyridamole].[白细胞和血小板在失血性休克肺损伤中的作用。阿司匹林和双嘧达莫的保护作用]
Patol Fiziol Eksp Ter. 1983 Nov-Dec(6):5-8.
5
Antiplatelet therapy.
Clin Haematol. 1981 Jun;10(2):497-520.
6
Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates.退伍军人管理局关于坏疽截肢术后糖尿病患者抗血小板药物的合作研究：II. 阿司匹林和双嘧达莫对动脉粥样硬化血管疾病发生率的影响。
Diabetes Care. 1986 Mar-Apr;9(2):140-8. doi: 10.2337/diacare.9.2.140.
7
Use of common antiplatelet drugs for vascular diseases.常见抗血小板药物在血管疾病中的应用。
Geriatrics. 1983 Nov;38(11):75-95.
8
The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.抗血小板治疗对隐静脉冠状动脉旁路移植血管通畅率的影响。
Circulation. 1983 Sep;68(3 Pt 2):II218-21.
9
The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.阿司匹林剂量对糖尿病和非糖尿病患者血小板功能的影响：来自阿司匹林诱导血小板效应（ASPECT）研究的分析。
Diabetes. 2007 Dec;56(12):3014-9. doi: 10.2337/db07-0707. Epub 2007 Sep 11.
10
Antiplatelet agents in prevention of myocardial infarction.
Indian Heart J. 1983 Jan-Feb;35(1):60-6.
本文引用的文献
1
Increased platelet thromboxane synthesis in diabetes mellitus.糖尿病中血小板血栓素合成增加。
J Lab Clin Med. 1981 Jan;97(1):87-96.
2
Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients.与从糖尿病患者血清中纯化的可溶性免疫复合物孵育后血小板的聚集及ATP的释放。
Diabetes. 1981 Jul;30(7):575-9. doi: 10.2337/diab.30.7.575.
3
Pathogenesis of atherosclerosis in diabetes mellitus.
Diabetes Care. 1981 Jan-Feb;4(1):121-33. doi: 10.2337/diacare.4.1.121.
4
Platelet function in diabetes mellitus.糖尿病中的血小板功能。
Br J Haematol. 1980 Apr;44(4):521-6. doi: 10.1111/j.1365-2141.1980.tb08705.x.
5
Platelet survival in streptozotocin-induced diabetic rats.链脲佐菌素诱导的糖尿病大鼠的血小板存活情况
Thromb Haemost. 1984 Jul 29;51(3):307-12.
6
New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.
Am J Med. 1983 Nov 30;75(5B):67-80. doi: 10.1016/0002-9343(83)90256-5.
7
8
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics.退伍军人事务部糖尿病患者坏疽截肢后抗血小板药物合作研究：I. 设计、方法和基线特征
Control Clin Trials. 1984 Jun;5(2):165-83. doi: 10.1016/0197-2456(84)90122-3.
9
Increased platelet aggregation in diabetes mellitus.
J Lab Clin Med. 1972 Aug;80(2):236-46.
10
Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation.
Diabetes. 1972 Feb;21(2):108-13. doi: 10.2337/diab.21.2.108.
Zotero 插件